UPDATE
: Thursday, December 5, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why?
The boycott of Japanese products has been intensifying over the past few mo...
by Lee Han-soo
|
2019-08-30 15:58
라인
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
JW Pharmaceutical said more countries have recognized that its cholesterol-...
by Jeong Sae-im
|
2019-08-30 14:49
라인
'Mucosa healing essential for treating inflammatory bowel disease'
Takeda's Kynteles (Ingredient: Vedolizumab) is attempting a paradigm sh...
by Lee Han-soo
|
2019-08-30 12:42
라인
CAR-T therapy Kymriah, pie in the sky for Korean patients
Kymriah, Novartis’ new CAR-T (chimeric antigen receptor T-cell) treatment, ...
by Kim Yun-mi
|
2019-08-29 14:35
라인
Ildong’s subsidiary secures 1st anticancer drug pipeline
Idience, a subsidiary of Ildong Pharmaceutical, has acquired IDX-1197, an i...
by Lee Han-soo
|
2019-08-29 13:37
라인
Prosecutors raid Sillajen over alleged use of undisclosed information
The prosecution on Wednesday carried out simultaneous raids on Sillajen'...
by Lee Han-soo
|
2019-08-29 11:27
라인
Antidiabetic DPP-4 inhibitors mark double-digit sales growth
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, have ...
by Jeong Sae-im
|
2019-08-29 11:24
라인
Crystal Genomics' immunotherapy gets orphan drug status from US regulator
Crystal Genomics' CG-745, a molecular immunotherapy for pancreatic canc...
by Lee Han-soo
|
2019-08-28 17:44
라인
FDA OKs Boryung's P1 trial for immunotherapy candidate
Boryung Pharmaceutical said that the U.S. Food and Drug Administration has ...
by Lee Han-soo
|
2019-08-28 14:21
라인
Sales of new gastric acid blocker K-Cab top ₩10 billion
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded over 10 ...
by Jeong Sae-im
|
2019-08-28 13:26
라인
Leo Pharma submits IND application for JW Pharmaceutical’s atopy treatment
JW Pharmaceutical said that Leo Pharma, a Denmark-based multinational pharm...
by Lee Han-soo
|
2019-08-28 13:24
라인
Pharmacists demand audit over Gliatilin’s insurance benefit
A pharmacists’ group demanded an audit against the Ministry of Health and W...
by Song Soo-youn
|
2019-08-27 16:01
라인
HLB to test rivoceranib+Lonsurf in colon cancer
HLB said it would test a combination therapy using rivoceranib with Lonsurf...
by Jeong Sae-im
|
2019-08-27 15:39
라인
Pharmaceutical sector’s job growth twice of all industries’ average
The pharmaceutical industry’s employment growth rate was eight times higher...
by Jeong Sae-im
|
2019-08-26 11:39
라인
Invossa still effective despite mislabeling, maker claims
Kolon Life Science said that U.S. orthopedic surgeons had published a resea...
by Lee Han-soo
|
2019-08-23 20:16
라인
Vivozon finishes P3 trial for nonnarcotic analgesics
Vivozon, a local biopharmaceutical company, said Friday that it has complet...
by Lee Han-soo
|
2019-08-23 16:03
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
HLB said Thursday it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im
|
2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
Haim Bio said that the Ministry of Food and Drug Safety has approved its in...
by Lee Han-soo
|
2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
Peptron said it has confirmed that PT320, a Parkinson's disease treatme...
by Lee Han-soo
|
2019-08-22 17:53
라인
‘Drug firm’s pick of doctor to attend conference overseas illegal’
Pharmaceutical companies’ support for physicians to attend academic confere...
by Kim Yun-mi
|
2019-08-22 15:45
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
Korea exports health insurance system to Bahrain
‘Lynparza raises value of precision medicine as anticancer treatment’
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Roche Diagnostics stresses ‘integrated personalized diabetes management’
Korea exports health insurance system to Bahrain
‘Lynparza raises value of precision medicine as anticancer treatment’
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Roche Diagnostics stresses ‘integrated personalized diabetes management’
여백
Most viewed
1
Syntekabio views industry’s crisis as opportunity
2
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
3
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
4
Technology developed to detect inflammatory disorders early
5
GC MS wins US patent for influenza diagnostic technology
6
‘Obesity needs to be treated as a chronic disease’
7
Alteogen inks licensing-out deal for SC injection formulation technology
8
[Special] Trainee doctors fear medical mishaps amid severe shortage of workforce
9
Samyang Biopharm’s US subsidiary to work on new immunotherapy
10
Swedish researchers divide Type 2 diabetes into 5 subgroups
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top